Effective clinical development planning is increasingly challenging for sponsors. With increasingly complicated protocols and the global nature of clinical development, many find their scientific and clinical expertise stretched in the pursuit of a development plan that maximizes the value of their investments.
WCG’s global network of scientific and clinical development experts stand ready to review your clinical development plan and provide critical recommendations that will ensure you maximize the returns on investment in your drug development program.
WCG’s leadership team, supplemented by our global network of medical experts, has decades of experience in planning and advising on how best to conduct clinical trial activities across the product development spectrum in virtually every region and therapeutic area.
Let our global experts review your trial design: schedule a consultation.
Design and analysis methodologies for pharmaceutical research, spanning from pre-clinical through clinical trials, to real-world evidence.
Reviews of the scientific and medical aspect of your clinical development paths and estimated time to market.
Reviews that can unlock more opportunities to drive value from your development plan through additional or modified development paths.
Enhancing trial integrity and reducing variation in important clinical trial events are critical components of risk mitigation and patient safety. To improve the quality and effectiveness of clinical trial data requires regulatory expertise; through ACI’s endpoint adjudication and data monitoring safety committees, sponsors and CROs can benefit from a network of 550 members to enable more informed decision-making. Their expert reviews deliver reliable, trusted information to support critical decisions around clinical development programs.
To explore how we can help with your scientific review requirements, we suggest an exploratory conversation to assess your plans and how our capabilities can be leveraged to assist. To start, simply fill out the form.